Suppr超能文献

唐氏综合征和阿尔茨海默病 Ts65Dn 鼠模型中 CA1 锥体神经元基因表达镶嵌现象,经母体补充胆碱后。

CA1 pyramidal neuron gene expression mosaics in the Ts65Dn murine model of Down syndrome and Alzheimer's disease following maternal choline supplementation.

机构信息

Center for Dementia Research, Nathan Kline Institute, Orangeburg, New York.

Department of Psychiatry, New York University Langone Medical Center, New York, New York.

出版信息

Hippocampus. 2018 Apr;28(4):251-268. doi: 10.1002/hipo.22832. Epub 2018 Feb 12.

Abstract

Although there are changes in gene expression and alterations in neuronal density and afferent inputs in the forebrain of trisomic mouse models of Down syndrome (DS) and Alzheimer's disease (AD), there is a lack of systematic assessments of gene expression and encoded proteins within individual vulnerable cell populations, precluding translational investigations at the molecular and cellular level. Further, no effective treatment exists to combat intellectual disability and basal forebrain cholinergic neurodegeneration seen in DS. To further our understanding of gene expression changes before and following cholinergic degeneration in a well-established mouse model of DS/AD, the Ts65Dn mouse, we assessed RNA expression levels from CA1 pyramidal neurons at two adult ages (∼6 months of age and ∼11 months of age) in both Ts65Dn and their normal disomic (2N) littermates. We further examined a therapeutic intervention, maternal choline supplementation (MCS), which has been previously shown to lessen dysfunction in spatial cognition and attention, and have protective effects on the survival of basal forebrain cholinergic neurons in the Ts65Dn mouse model. Results indicate that MCS normalized expression of several genes in key gene ontology categories, including synaptic plasticity, calcium signaling, and AD-associated neurodegeneration related to amyloid-beta peptide (Aβ) clearance. Specifically, normalized expression levels were found for endothelin converting enzyme-2 (Ece2), insulin degrading enzyme (Ide), Dyrk1a, and calcium/calmodulin-dependent protein kinase II (Camk2a), among other relevant genes. Single population expression profiling of vulnerable CA1 pyramidal neurons indicates that MCS is a viable therapeutic for long-term reprogramming of key transcripts involved in neuronal signaling that are dysregulated in the trisomic mouse brain which have translational potential for DS and AD.

摘要

尽管唐氏综合征(DS)和阿尔茨海默病(AD)的三体鼠模型的前脑存在基因表达的变化和神经元密度及传入输入的改变,但对于单个易损细胞群体内的基因表达和编码蛋白缺乏系统评估,从而阻碍了分子和细胞水平的转化研究。此外,针对 DS 中存在的智力障碍和基底前脑胆碱能神经退行性变,目前尚无有效的治疗方法。为了进一步了解在一种成熟的 DS/AD 小鼠模型 Ts65Dn 中,胆碱能退行性变前后的基因表达变化,我们评估了两个成年年龄(约 6 个月和 11 个月)的 Ts65Dn 及其正常二倍体(2N)同窝仔鼠 CA1 锥体神经元的 RNA 表达水平。我们进一步研究了一种治疗干预措施,即母体胆碱补充(MCS),它先前已显示出减轻空间认知和注意力功能障碍,并对 Ts65Dn 小鼠模型中的基底前脑胆碱能神经元的存活具有保护作用。结果表明,MCS 使几个关键基因本体论类别的基因表达正常化,包括突触可塑性、钙信号和与淀粉样β肽(Aβ)清除相关的 AD 相关神经退行性变。具体而言,发现内皮素转换酶-2(Ece2)、胰岛素降解酶(Ide)、Dyrk1a 和钙/钙调蛋白依赖性蛋白激酶 II(Camk2a)等相关基因的表达水平正常化。易损 CA1 锥体神经元的单一群体表达谱分析表明,MCS 是一种可行的治疗方法,可长期重编程参与神经元信号转导的关键转录物,这些转录物在三体鼠脑中失调,具有针对 DS 和 AD 的转化潜力。

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验